Month: April 2020

(Reuters) – Gilead Sciences Inc, maker of the experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment. FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe
0 Comments
FILE PHOTO: Former national security adviser Michael Flynn exits a vehicle as he arrives for his sentencing hearing at U.S. District Court in Washington, U.S., December 18, 2018. REUTERS/Jonathan Ernst WASHINGTON (Reuters) – U.S. President Donald Trump said on Thursday his former national security adviser, Michael Flynn, was tormented by “dirty cops” as part of
0 Comments
ZURICH (Reuters) – Researchers in Switzerland have been able to detect the new corovarirus at even low concentrations in wastewater, offering a potential early warning system for flareups in infections as countries emerge from emergency lockdowns. Should the system work, sewage samples could let public health officials see a resurgence of COVID-19 infections earlier than
0 Comments
CHICAGO (Reuters) – Concerns over leaks compelled the top U.S. infectious disease official to reveal data on Gilead Sciences Inc’s (GILD.O) experimental drug remdesivir, the first in a scientifically rigorous clincial trial to show benefit in treating COVID-19. National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci attends a coronavirus response meeting between
0 Comments